Literature DB >> 27826698

MR imaging of atypical fibroids.

Candice Bolan1, Melanie P Caserta2.   

Abstract

Leiomyomas are the most common neoplasm found in the uterus and can present with a variety of symptoms or be entirely asymptomatic. Most often, the characteristic imaging appearance of leiomyoma does not pose a diagnostic dilemma. However, leiomyomas can demonstrate atypical imaging features that may be confusing. It is essential for the radiologist to be aware of both the typical and atypical findings to better assist the referring clinician with diagnosis and management decisions. Additionally, as uterine-sparing treatment alternatives with locoregional therapies become more popular, it is important to be aware of pre- and post-procedural imaging questions that may be encountered. Lastly, when atypical features are seen, it is important to understand the characteristics that may suggest a diagnosis of leiomyosarcoma. The goal of this study is to review imaging features of atypical leiomyoma with case-based examples.

Entities:  

Keywords:  Atypical; Degenerated fibroid; Fibroids; Leiomyosarcoma; MRI

Mesh:

Year:  2016        PMID: 27826698     DOI: 10.1007/s00261-016-0935-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  10 in total

1.  Uterine smooth muscle tumours with hyperintense area on T1 weighted images: differentiation between leiomyosarcomas and leiomyomas.

Authors:  Tomohiro Ando; Hiroki Kato; Tatsuro Furui; Ken-Ichirou Morishige; Satoshi Goshima; Masayuki Matsuo
Journal:  Br J Radiol       Date:  2018-01-18       Impact factor: 3.039

Review 2.  Systematic radiological approach to utero-ovarian pathologies.

Authors:  Olivera Nikolic; Marijana Basta Nikolic; Aleksandar Spasic; Mila Milagros Otero-Garcia; Sanja Stojanovic
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

3.  Structured vs narrative reporting of pelvic MRI for fibroids: clarity and impact on treatment planning.

Authors:  Andrea Franconeri; Jieming Fang; Benjamin Carney; Almamoon Justaniah; Laura Miller; Hye-Chun Hur; Louise P King; Roa Alammari; Salomao Faintuch; Koenraad J Mortele; Olga R Brook
Journal:  Eur Radiol       Date:  2017-12-15       Impact factor: 5.315

Review 4.  MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space-based Approach.

Authors:  Stephanie Nougaret; Ines Nikolovski; Viktoriya Paroder; Hebert A Vargas; Evis Sala; Sebastien Carrere; Raphael Tetreau; Christine Hoeffel; Rosemarie Forstner; Yulia Lakhman
Journal:  Radiographics       Date:  2019 Jul-Aug       Impact factor: 5.333

Review 5.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

6.  Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.

Authors:  Parisa Aminzadeh; Ekaterina Alibrahim; Andrew Dobrotwir; Eldho Paul; Stacy Goergen
Journal:  Br J Radiol       Date:  2021-01-28       Impact factor: 3.039

Review 7.  MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.

Authors:  Vlad Bura; Roxana Maria Pintican; Reka Emma David; Helen Clare Addley; Janette Smith; Mercedes Jimenez-Linan; Janice Lee; Susan Freeman; Carmen Georgiu
Journal:  Br J Radiol       Date:  2021-07-21       Impact factor: 3.629

Review 8.  Ultrasonography of uterine leiomyomas.

Authors:  Andrzej Woźniak; Sławomir Woźniak
Journal:  Prz Menopauzalny       Date:  2017-12-30

9.  Diffusion-weighted imaging of the female pelvis: how to avoid pitfalls.

Authors:  Alice Brandão
Journal:  Radiol Bras       Date:  2018 Mar-Apr

Review 10.  Differentiating uterine sarcoma from leiomyoma: BET1T2ER Check!

Authors:  Janette Smith; Jeries Paolo Zawaideh; Hilal Sahin; Susan Freeman; Helen Bolton; Helen Clare Addley
Journal:  Br J Radiol       Date:  2021-05-05       Impact factor: 3.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.